| Range: | 200.0-882.85626 | Vol Avg: | 11 | Last Div: | 0 | Changes: | -100.5 |
| Beta: | 1.02 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Oct 15 2014 | Empoloyees: | 4 | ||
| CUSIP: | CIK: | ISIN: | US34986J3032 | Country: | DK | ||
| CEO: | Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D. | Website: | https://www.forward-pharma.com | ||||
FWPAY 2.46 Stock Price Forward Pharma A/S
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow